Parotid-sparing radiotherapy: Does it really reduce xerostomia?

Clinical Oncology

Volumn 17, Issue 8, 2005, Pages 610-617

  Ng, Michael K ^a   Porceddu, S V ^b   Milner, A D ^a   Corry, J ^a   Hornby, C ^a   Hope, G ^a   Rischin, D ^a   Peters, L J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Head and neck cancer; Parotid; Quality of life; Radiotherapy; Three dimensional treatment planning; Xerostomia

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CANCER; OROPHARYNX CANCER; PAROTID GLAND; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RADIATION FIELD; RATING SCALE; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PAROTID GLAND; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, CONFORMAL; XEROSTOMIA;

EID: 28244491150     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2005.06.012     Document Type: Article

References (34)

1. L.B. Harrison M.J. Zelefsky D.G. Pfister et al Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue Head Neck 19 1997 169-175
2. K. Bjordal S. Kaasa A. Mastekaasa Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy Int J Radiat Oncol Biol Phys 28 1994 847-856
3. S.R. Porter C. Scully A.M. Hegarty An update of the etiology and management of xerostomia Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 2004 28-46
4. F.G. LeVeque M. Montgomery D. Potter et al A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients J Clin Oncol 11 1993 1124-1131
5. P. Warde B. O'Sullivan J. Aslanidis et al A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer Int J Radiat Oncol Biol Phys 54 2002 9-13
6. J.C. Horiot F. Lipinski S. Schraub et al Post-radiation severe xerostomia relieved by pilocarpine: A prospective French cooperative study Radiother Oncol 55 2000 233-239
7. I.H. Valdez A. Wolff J.C. Atkinson A.A. Macynski P.C. Fox Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction Cancer 71 1993 1848-1851
8. J.T. Johnson G.A. Ferretti W.J. Nethery et al Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer N Engl J Med 329 1993 390-395
9. D.M. Brizel T.H. Wasserman M. Henke et al Phase III randomized trial of amifostine as a radioprotector in head and neck cancer J Clin Oncol 18 2000 3339-3345
10. J. Buntzel M. Glatzel K. Kuttner R. Weinaug D. Frohlich Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer Semin Radiat Oncol 12 2002 4-13
11. A. Eisbruch R.K. Ten Haken H.M. Kim L.H. Marsh J.A. Ship Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer Int J Radiat Oncol Biol Phys 45 1999 577-587
12. A. Eisbruch H.M. Kim J.E. Terrell L.H. Marsh L.A. Dawson J.A. Ship Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 695-704
13. J.E. Marks C.C. Davis V.L. Gottsman J.E. Purdy F. Lee The effects of radiation of parotid salivary function Int J Radiat Oncol Biol Phys 7 1981 1013-1019
14. K.S. Chao J.O. Deasy J. Markman et al A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results Int J Radiat Oncol Biol Phys 49 2001 907-916
15. L.A. Dawson Y. Anzai L. Marsh et al Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 46 2000 1117-1126
16. K.S. Chao G. Ozyigit B.N. Tran M. Cengiz J.F. Dempsey D.A. Low Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer Int J Radiat Oncol Biol Phys 55 2003 312-321
17. B. Bussels A. Maes R. Hermans S. Nuyts C. Weltens W. Van Den Bogaert Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer Radiother Oncol 72 2004 119-127
18. M.W. Munter C.P. Karger S.G. Hoffner et al Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy Int J Radiat Oncol Biol Phys 58 2004 175-184
19. I.H. Liem R.A. Olmos A.J. Balm et al Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours Eur J Nucl Med 23 1996 1485-1490
20. B.S. Henson M.R. Inglehart A. Eisbruch J.A. Ship Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy Oral Oncol 37 2001 84-93
21. A. Eisbruch J.A. Ship M.K. Martel et al Parotid gland sparing in patients undergoing bilateral head and neck irradiation: Techniques and early results Int J Radiat Oncol Biol Phys 36 1996 469-480
22. A. Lin H.M. Kim J.E. Terrell L.A. Dawson J.A. Ship A. Eisbruch Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study Int J Radiat Oncol Biol Phys 57 2003 61-70
23. R.P. Zimmerman R.J. Mark L.M. Tran G.F. Juillard Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia Int J Radiat Oncol Biol Phys 37 1997 571-575
24. J. Corry D. Rischin J.G. Smith et al Radiation with concurrent late chemotherapy intensification ('chemoboost') for locally advanced head and neck cancer Radiother Oncol 54 2000 123-127
25. D. Rischin L. Peters R. Fisher et al Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: A randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02) J Clin Oncol 23 2005 79-87
26. D. Rischin J. Corry J. Smith J. Stewart P. Hughes L. Peters Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation J Clin Oncol 20 2002 1845-1852
27. S-plus 2000 1999 Mathsoft Inc Seattle, WA
28. M. Al-Sarraf M. LeBlanc P.G. Giri et al Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310-1317
29. J.P. Pignon J. Bourhis C. Domenge L. Designe Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer Lancet 355 2000 949-955
30. G. Calais Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [in French] Cancer Radiother 2 1998 469-474
31. J.G. Malouf C. Aragon B.S. Henson A. Eisbruch J.A. Ship Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients Cancer Detect Prev 27 2003 305-310
32. L. Franzen U. Funegard T. Ericson R. Henriksson Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort Eur J Cancer 28 1992 457-462
33. C. Dawes Rhythms in salivary flow rate and composition Int J Chronobiol 2 1974 253-279
34. C. Dawes C.M. Wood The contribution of oral minor mucous gland secretions to the volume of whole saliva in man Arch Oral Biol 18 1973 337-342